Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Several devicemakers are using a new blood perfusion technology to transform the way donor organs are preserved and transferred, reports NBC News.
Bristol-Myers Squibb lost $37 billion in market value this past year due to a failed clinical trial for a new lung cancer treatment indication of its best-selling cancer drug Opdivo. Industry analysts believe the financial setback puts the drugmaker in…
The Food and Drug Administration on Thursday approved Qiagen's fourth generation tuberculosis blood test.
A new report conducted by Patient View, a patient insight organization, explores the corporate reputation of the pharmacy industry from the perspective of cancer patients.
HHS Secretary Tom Price, MD, reiterated the importance of lowering prescription drug costs during a Thursday hearing with the Senate Finance Committee, reports Bloomberg,
The congressional MedTech caucus held a briefing Thursday about technological advancements made toward curbing cardiovascular disease.
The House Energy and Commerce Committee on June 7 unanimously passed a bill to reauthorize the Food and Drug Administration's user fee program, the Washington Examiner reports.
Here are the five latest drugs, medical devices or mobile applications approved by the Food and Drug Administration this week.
The Food and Drug Administration approved a labeling change to Hologic's Genius 3-D Mammography test.
The Nevada legislature restored a bill that would improve price transparency by requiring insulin manufacturers to disclose their profits, according to Kaiser Health News.